Member Info for AllAtSea

Out of 18 stocks only 3 in profit. However, I am reasonably happy with most. Holding onto OCDO is a gamble and really at 75% down they simply are not worth selling, they are my smallest by value by far.

I did begin to worry about shareholder liability to creditors, that sort of thing, but it looks like I am off the hook on that one.

Agree totally CJ39. Had to wait until today to get the interim but I stuck it all on AV. early this morning.

Not convinced anything will happen soon so I have taken my profits till the next dip.

on the 22nd.

Might get back in if it goes a little lower but there are plenty other opportunities right now.

Got out a while back. It was a gamble, I have no idea where this is heading of course.

So it is "a truism that politics trumps economics".

However if..
"The best way of funding this over time will be the taxes levied on wealthier households. No politician who wants to get elected traditionally says such things."

Then it is also a truism that billionaires trump politics. There is no reason to think that will change under a new prime minister.

The damage inflicted on the country, the entire UK, is a direct result of electing politicians who are in thrall to billionairedom. The damage inflicted on the value of UK companies is the doing of the billionaires and their chosen people.

https://finance.yahoo.com/news/ftse-100-bosses-average-pay-jumps-113721802.html

"Luke Hildyard, director of the High Pay Centre, said: “Very high executive pay is a big part of the cost of living problem. If large employers are paying millions more to already very wealthy executives, that makes it harder to fund pay increases for low and middle-income workers.”

The TUC and the High Pay Centre are calling for reforms to regulations affecting corporate pay-setting processes, including requirements for companies to include a minimum of two elected workforce representatives on the remuneration committees that set pay."

We must not be envious, clearly give the performance of my portfolio, they have earned it. Without these CEOs, instead of being worth a lot less than it was , it would be completely worthless. And don't forget the (almost) inflation-beating dividends. Envy is for leftie-trouble makers.

After hours price of GSK rose to 1420.

Sorry guys, I just sold. Needed the funds elsewhere.

Given the state of my other stocks, I could sell these now and grab bargains(?) elsewhere.

I read this evening that The Fool reckons GSK is a good long term buy at this level. Suggests that GSK's performance means the legal costs are manageable.
https://www.fool.co.uk/2022/08/18/should-i-snap-up-gsk-shares-at-14/

Having bought two top ups since the news broke, I guess that makes me a Fool!

But it will rise just before you want to reinvest the dividend.

FT article today says TB's recent US takeovers have come at multiples of more than ten times trailing 12 months sales. Suggests they will go higher.

Dieselgate compo is the latest show in town. I did have a diesel a while back but no way am I signing up on some unknown shyster's database on the off-chance. I am still getting those sinister phone calls about 'You have recently had an accident..', it was only a cut finger ferchrissake.. It'll grow back.

(No disrespect to any honest legal eagles intended)

It is bizarre how something that was not unknown suddenly got hauled under spotlight at this moment. Almost like it was planned.

" The number of claims made against GSK and others is still relatively low, compared to some other recent high-profile class-action lawsuits against big pharma companies - although that could certainly change if some claimants start to achieve success at court. The first personal injury claim linking Zantac to cancer is set to be heard in a court in Illinois later this month."

That's in the next fortnight.

Our US rivals will be very influential maybe.. I would not like to bet which way though.

Just used this drop to ditch a speculation and buy more GSK. I've not lost buying GSK, just had to be very patient.

FT:
“ It’s lunchtime in London and GSK is worth about £5bn less than it was first thing this morning in response to essentially no news...”

And

“All this was already in the public domain even before Haleon’s prospectus dropped six weeks ago, but since it’s on page 292 perhaps investors have only just reached the most interesting bit, which is this:

Whilst Pfizer and GSK have each served CH JVCo [Haleon’s holding company] with notice of potential claims under the relevant indemnification provisions in the Pfizer SAPA in relation to possible liabilities connected with OTC Zantac, it is not possible, at this stage, to meaningfully assess whether the outcome will result in a probable outflow, or to quantify or reliably estimate what liability (if any) that CH JVCo may have to the GSK Group and/or the Pfizer Group under the relevant indemnities. This is due to a number of factors and uncertainties, including [?.?.?.?] the complex factual matrix relating to the third-party tort claims and the implications of the history of ownership of the US OTC Zantac rights [and] the current status of the respective proceedings, which remain at an early stage.”

Tempted to take profits and buy HLN.